Extended dosing of darbepoetin alfa in peritoneal dialysis patients

BACKGROUND: Anemia is common among peritoneal dialysis (PD) patients, and most patients require erythropoiesis-stimulating agents (ESA) to maintain their hemoglobin concentrations within current guideline recommendations. Darbepoetin alfa is an ESA with a 3-fold longer half-life and greater in vivo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Feriani, Mariano, De Meester, Johan MJ, McMahon, Lawrence P, Rottembourg, Jacques B, Bridges, Ian, Farouk, Mourad, Pronai, Wolfgang
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2011
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3072319/
https://ncbi.nlm.nih.gov/pubmed/21435267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-12-13
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars